Matches in SemOpenAlex for { <https://semopenalex.org/work/W2903560900> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2903560900 endingPage "739" @default.
- W2903560900 startingPage "733" @default.
- W2903560900 abstract "To observe the efficacy and safety of Shaoyang Xibi decoction (SYXBD) in patients with knee osteoarthritis (KOA), and to verify that the theory of “Shaoyang dominating bone” in Traditional Chinese Medicine (TCM) can be applied to KOA treatment. Participants were randomly allocated to two groups: SYXBD (treatment group, n = 66) and Meloxicam (control group, n = 66). Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and 36-Item Short Form Health Survey (SF-36) were used to assess efficacy before the treatment and 8 weeks after the treatment. Baseline data before the treatment between the two groups were similar. The WOMAC scores significantly decreased and the SF-36 scores significantly increased after 8- week treatment in both groups compared with before the treatment (P < 0.05). SYXBD significantly decreased pain scores (P < 0.001), physical function scores (P < 0.001) and the total scores (P < 0.001) in WOMAC compared to Meloxicam. SYXBD significantly improved physical function (P = 0.021), bodily pain (P = 0.002) and general health (P = 0.014), with no significant difference in role emotional (P = 0.053), role physical (P = 0.517), vitality (P = 0.241), social function (P = 0.712) and mental health (P = 0.800) in SF-36 compared to Meloxicam. No adverse events were reported in the treatment group while 13 adverse events happened in the control group during the study. SYXBD, prepared based on the theory of “Shaoyang dominating bone”, has a better curative efficay and safety in patients with KOA compared with Meloxicam. The TCM theory of “Shaoyang dominating bone” may be useful in KOA treatment." @default.
- W2903560900 created "2018-12-11" @default.
- W2903560900 creator A5010818765 @default.
- W2903560900 creator A5014483604 @default.
- W2903560900 creator A5018114512 @default.
- W2903560900 creator A5039627663 @default.
- W2903560900 creator A5043254171 @default.
- W2903560900 creator A5045225650 @default.
- W2903560900 creator A5065323034 @default.
- W2903560900 creator A5074121633 @default.
- W2903560900 date "2018-10-01" @default.
- W2903560900 modified "2023-10-06" @default.
- W2903560900 title "Efficacy and safety of Shaoyang Xibi decoction in patients with knee osteoarthritis: a multi-center, single-blind, randomized controlled trial" @default.
- W2903560900 cites W1967057044 @default.
- W2903560900 cites W1986369093 @default.
- W2903560900 cites W2026561294 @default.
- W2903560900 cites W2058147305 @default.
- W2903560900 cites W2102272680 @default.
- W2903560900 cites W819151961 @default.
- W2903560900 cites W849946536 @default.
- W2903560900 doi "https://doi.org/10.1016/s0254-6272(18)30912-9" @default.
- W2903560900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32185990" @default.
- W2903560900 hasPublicationYear "2018" @default.
- W2903560900 type Work @default.
- W2903560900 sameAs 2903560900 @default.
- W2903560900 citedByCount "9" @default.
- W2903560900 countsByYear W29035609002020 @default.
- W2903560900 countsByYear W29035609002021 @default.
- W2903560900 countsByYear W29035609002022 @default.
- W2903560900 countsByYear W29035609002023 @default.
- W2903560900 crossrefType "journal-article" @default.
- W2903560900 hasAuthorship W2903560900A5010818765 @default.
- W2903560900 hasAuthorship W2903560900A5014483604 @default.
- W2903560900 hasAuthorship W2903560900A5018114512 @default.
- W2903560900 hasAuthorship W2903560900A5039627663 @default.
- W2903560900 hasAuthorship W2903560900A5043254171 @default.
- W2903560900 hasAuthorship W2903560900A5045225650 @default.
- W2903560900 hasAuthorship W2903560900A5065323034 @default.
- W2903560900 hasAuthorship W2903560900A5074121633 @default.
- W2903560900 hasBestOaLocation W29035609001 @default.
- W2903560900 hasConcept C126322002 @default.
- W2903560900 hasConcept C142724271 @default.
- W2903560900 hasConcept C168563851 @default.
- W2903560900 hasConcept C1862650 @default.
- W2903560900 hasConcept C190409667 @default.
- W2903560900 hasConcept C197934379 @default.
- W2903560900 hasConcept C204787440 @default.
- W2903560900 hasConcept C2776164576 @default.
- W2903560900 hasConcept C2779286237 @default.
- W2903560900 hasConcept C2779751750 @default.
- W2903560900 hasConcept C71924100 @default.
- W2903560900 hasConceptScore W2903560900C126322002 @default.
- W2903560900 hasConceptScore W2903560900C142724271 @default.
- W2903560900 hasConceptScore W2903560900C168563851 @default.
- W2903560900 hasConceptScore W2903560900C1862650 @default.
- W2903560900 hasConceptScore W2903560900C190409667 @default.
- W2903560900 hasConceptScore W2903560900C197934379 @default.
- W2903560900 hasConceptScore W2903560900C204787440 @default.
- W2903560900 hasConceptScore W2903560900C2776164576 @default.
- W2903560900 hasConceptScore W2903560900C2779286237 @default.
- W2903560900 hasConceptScore W2903560900C2779751750 @default.
- W2903560900 hasConceptScore W2903560900C71924100 @default.
- W2903560900 hasIssue "5" @default.
- W2903560900 hasLocation W29035609001 @default.
- W2903560900 hasLocation W29035609002 @default.
- W2903560900 hasOpenAccess W2903560900 @default.
- W2903560900 hasPrimaryLocation W29035609001 @default.
- W2903560900 hasRelatedWork W1985286937 @default.
- W2903560900 hasRelatedWork W1988810699 @default.
- W2903560900 hasRelatedWork W2045407791 @default.
- W2903560900 hasRelatedWork W2095773979 @default.
- W2903560900 hasRelatedWork W2317839817 @default.
- W2903560900 hasRelatedWork W2322423563 @default.
- W2903560900 hasRelatedWork W3092039494 @default.
- W2903560900 hasRelatedWork W4312398015 @default.
- W2903560900 hasRelatedWork W4317104327 @default.
- W2903560900 hasRelatedWork W4327515429 @default.
- W2903560900 hasVolume "38" @default.
- W2903560900 isParatext "false" @default.
- W2903560900 isRetracted "false" @default.
- W2903560900 magId "2903560900" @default.
- W2903560900 workType "article" @default.